CN111529629A - Traditional Chinese medicine composition for treating cervical vertebra and lumbar vertebra bone diseases - Google Patents
Traditional Chinese medicine composition for treating cervical vertebra and lumbar vertebra bone diseases Download PDFInfo
- Publication number
- CN111529629A CN111529629A CN202010384711.9A CN202010384711A CN111529629A CN 111529629 A CN111529629 A CN 111529629A CN 202010384711 A CN202010384711 A CN 202010384711A CN 111529629 A CN111529629 A CN 111529629A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- medicine composition
- treating cervical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Insects & Arthropods (AREA)
- Animal Husbandry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the technical field of traditional Chinese medicine prescriptions, in particular to a traditional Chinese medicine composition for treating cervical vertebra and lumbar vertebra diseases, which is prepared from the following medicinal materials in parts by weight: 50-200 parts of spina gleditsiae, 400-1500 parts of caulis spatholobi, 7-30 parts of rhizoma drynariae, 6-25 parts of eucommia ulmoides, 2-4 parts of lycopodium clavatum, 1-3 parts of cucumber seeds, 3-5 parts of ground beeltle, 0.6-0.8 part of astaxanthin extract, 2-3 parts of abelmoschus manihot extract, 3-5 parts of salvia miltiorrhiza, 3-6 parts of gastrodia elata, 2-6 parts of oldenlandia diffusa, 3-7 parts of dragon's blood, 1-2 parts of dalbergia wood and 1-3 parts of parasitic loranthus. Compared with the prior art, the invention has the advantages that: can effectively treat cervical spondylosis, lumbar disc herniation and hyperosteogeny, can reduce the occurrence of cold symptoms after being taken for a long time, and can effectively prevent hemorrhoids.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicine prescriptions, in particular to a traditional Chinese medicine composition for treating cervical vertebra and lumbar vertebra diseases.
Background
The lumbar disc herniation is caused by that the internal force of vertebral body muscles is increased, so that the stress of the intervertebral disc is uneven, the nucleus pulposus soft tissue is overflowed and adhered to nerve roots after the annulus fibrosus is ruptured to generate local edema and press the pain induced by nerves, the clinical symptoms of the lumbar disc herniation mainly comprise lower limb radiation pain, limited waist movement, waist pain, scoliosis, lameness and the like, the course of disease is long, and the normal life of a patient is seriously influenced; the lumbar disc herniation is called as the category of lumbago and arthralgia, and is mainly characterized by lumbago accompanied by pain or numbness of lower limbs, or lower abdominal pain and abnormal urination and defecation, and the disease is characterized by stubborn symptoms, long course of disease and easy relapse; at present, no effective treatment medicine for the disease exists in Western medicine, and symptomatic treatment is usually adopted.
Cervical spondylosis is also called cervical vertebra syndrome, is the general name of cervical osteoarthritis, proliferative cervical spondylitis, cervical radicle syndrome, cervical disc herniation, it is a disease that changes into the basic by degenerative pathology, mainly because cervical vertebra long-term strain, hyperosteogeny, or intervertebral disc prolapse, ligament thickening, cause cervical vertebra spinal cord, nerve root, or vertebral artery to be pressed, appear a series of clinical syndromes of dysfunctional, cervical spondylosis often presents the symptoms such as spinal instability, looseness, nucleus pulposus protrusion or prolapse, bony spur, ligament hypertrophy and secondary spinal stenosis, the above-mentioned organic pathological change can stimulate or oppress the adjacent nerve root, thus cause cervical pain, muscle strength to weaken, finger numbness, hold the weakness, dizziness and other symptoms, the method for treating cervical spondylosis includes oral medicine, traction method, operation, etc., but all there are different defects: the medicine has long treatment period and slow effect, and the long-term taking of the medicine can increase the gastrointestinal burden; the effect of traction method is limited in maintenance time, and when the muscle after traction is contracted again or the joint movement is limited, traction needs to be performed again; the treatment mode of the operation causes great pain to the patient and has higher risk degree.
The traditional Chinese medicine considers that the hyperosteogeny is mostly formed by the invasion of pathogenic wind, cold and dampness, so that qi and blood stagnation is blocked, obvious pain and discomfort are often brought to patients, the western medicine treatment is more troublesome, and the hyperosteogeny is easy to relapse after the medicine is stopped.
Disclosure of Invention
The invention aims to solve the problems in the background art, and provides a traditional Chinese medicine composition for treating cervical vertebra and lumbar vertebra diseases, which can effectively treat cervical spondylosis, lumbar disc herniation and hyperosteogeny.
In order to solve the technical problems, the technical scheme provided by the invention is as follows: a traditional Chinese medicine composition for treating cervical vertebra and lumbar vertebra bone diseases is prepared from the following medicinal materials in parts by weight: 50-200 parts of spina gleditsiae, 400-1500 parts of caulis spatholobi, 7-30 parts of rhizoma drynariae, 6-25 parts of eucommia ulmoides, 2-4 parts of lycopodium clavatum, 1-3 parts of cucumber seeds, 3-5 parts of ground beeltle, 0.6-0.8 part of astaxanthin extract, 2-3 parts of abelmoschus manihot extract, 3-5 parts of salvia miltiorrhiza, 3-6 parts of gastrodia elata, 2-6 parts of oldenlandia diffusa, 3-7 parts of dragon's blood, 1-2 parts of dalbergia wood and 1-3 parts of parasitic loranthus.
Further, the astaxanthin extract and the Abelmoschus manihot extract are powder.
Furthermore, the rootstock of the sargentgloryvine stem contains epinastine, enrofloxacin, isoschisanic acid, deoxyschizandrin, beta-sitosterol and stearic acid.
Furthermore, the usage of the caulis spatholobi is the same as that of the caulis spatholobi, the fragrance is stronger than that of the caulis spatholobi, the effect is better, but the growth is less, and the caulis spatholobi is used for replacing the caulis spatholobi when the caulis spatholobi does not exist.
Further, the sanguis Draxonis contains dracorhodin, demethyl dracorhodin, flavanol, chalcone, and resin acid.
Further, the spina gleditsiae contains flavonoid glycoside, phenols, amino acids, quercetin, fisetin, fustin, leucocyanidin and palmitic acid components.
Further, 50-200 parts of spina gleditsiae, 1500 parts of 400-fold euonymus fortunei, 7-30 parts of rhizoma drynariae, 6-25 parts of eucommia ulmoides, 2-4 parts of lycopodium clavatum, 1-3 parts of cucumber seeds, 3-5 parts of ground beeltle, 3-5 parts of salvia miltiorrhiza, 3-6 parts of gastrodia elata, 2-6 parts of oldenlandia diffusa, 3-7 parts of dragon's blood, 1-2 parts of dalbergia wood and 1-3 parts of parasitic loranthus, the materials are washed, dried in the sun and soaked in 3000 parts of wine containing 1500-fold euonymus, 0.6-0.8 part of astaxanthin extract and 2-3 parts of abelmoschus manihot extract are added, the medicinal liquor is taken twice a.
The invention has the beneficial effects that: on the basis of referring to the formulation idea of 'monarch, minister, assistant and guide' in the traditional Chinese medicine, the application reasonably applies various 'optimization methods' such as a 0.618 method, a contour method, a pre-giving requirement method and the like of the mathematician 'Hualuo heptyl', and combines the ingredients through repeated research and experiments for many years to conclude that the traditional Chinese medicine has the effects of nourishing nerves, promoting blood circulation to remove blood stasis, and relieving swelling and pain, is simple to prepare, low in price, good in curative effect, free of toxic and side effects, suitable for lumbar disc herniation, cervical spondylosis, osteoporosis and hyperosteogeny, basically free of relapse after being taken, capable of improving the secretion of hormones in vivo, capable of reducing the occurrence of cold symptoms after being taken for a long time, and capable of effectively.
Detailed Description
The invention is illustrated below by means of specific examples, without being restricted thereto.
Example one
50 parts of spina gleditsiae, 400 parts of caulis spatholobi, 7 parts of rhizoma drynariae, 6 parts of eucommia ulmoides, 2 parts of lycopodium clavatum, 1 part of cucumber seed, 3 parts of ground beeltle, 3 parts of salvia miltiorrhiza, 3 parts of gastrodia elata, 2 parts of oldenlandia diffusa, 3 parts of dragon's blood, 1 part of dalbergia wood and 1 part of loranthus parasiticus are washed, dried in the sun and soaked in 1500 parts of wine, 0.6 part of astaxanthin extract and 2 parts of abelmoschus manihot extract are added, and the medicinal liquor is taken twice a day, wherein the dosage.
Example two
100 parts of spina gleditsiae, 700 parts of caulis spatholobi, 15 parts of rhizoma drynariae, 12 parts of eucommia bark, 3 parts of lycopodium clavatum, 2 parts of cucumber seed, 4 parts of ground beeltle, 4 parts of salvia miltiorrhiza, 5 parts of gastrodia elata, 4 parts of oldenlandia diffusa, 5 parts of dragon's blood, 1.5 parts of dalbergia wood and 2 parts of parasitic loranthus are washed, dried in the sun and soaked in 2000 parts of wine, 0.7 part of astaxanthin extract and 2.5 parts of abelmoschus manihot extract are added, and the medicinal liquor is taken twice a day, wherein the dose is one or.
EXAMPLE III
200 parts of spina gleditsiae, 1500 parts of caulis spatholobi, 30 parts of rhizoma drynariae, 25 parts of eucommia bark, 4 parts of lycopodium clavatum, 3 parts of cucumber seed, 5 parts of ground beeltle, 5 parts of salvia miltiorrhiza, 6 parts of gastrodia elata, 6 parts of oldenlandia diffusa, 7 parts of dragon's blood, 2 parts of dalbergia wood and 3 parts of loranthus parasiticus are washed, dried in the sun and soaked in 000 parts of wine, 0.8 part of astaxanthin extract and 3 parts of abelmoschus manihot extract are added, and the medicinal wine is taken twice a day, wherein the dosage is.
Example four
Effect of caulis Seu folium Schisandrae Henryi on rehabilitation
Adding caulis Seu folium Schisandrae sinensis | Caulis Seu folium Schisandrae Henryi | |
After taking for one month | Basic rehabilitation | Unhealed |
After taking for two months | Rehabilitation | Good health and no recovery |
After three months of administration | Resistance enhancement | Slow down of symptoms and no recovery |
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.
Claims (7)
1. A traditional Chinese medicine composition for treating cervical vertebra and lumbar vertebra bone diseases is characterized by being prepared from the following medicinal materials in parts by weight: 50-200 parts of spina gleditsiae, 400-1500 parts of caulis spatholobi, 7-30 parts of rhizoma drynariae, 6-25 parts of eucommia ulmoides, 2-4 parts of lycopodium clavatum, 1-3 parts of cucumber seeds, 3-5 parts of ground beeltle, 0.6-0.8 part of astaxanthin extract, 2-3 parts of abelmoschus manihot extract, 3-5 parts of salvia miltiorrhiza, 3-6 parts of gastrodia elata, 2-6 parts of oldenlandia diffusa, 3-7 parts of dragon's blood, 1-2 parts of dalbergia wood and 1-3 parts of parasitic loranthus.
2. The traditional Chinese medicine composition for treating cervical and lumbar vertebra diseases according to claim 1, which is characterized in that: the astaxanthin extract and the abelmoschus manihot extract are powder.
3. The traditional Chinese medicine composition for treating cervical and lumbar vertebra diseases according to claim 1, which is characterized in that: the rootstock of the sargentgloryvine stem contains epinastine, enrofloxacin, isoschisanic acid, deoxyschizandrin, beta-sitosterol and stearic acid.
4. The traditional Chinese medicine composition for treating cervical and lumbar vertebra diseases according to claim 1, which is characterized in that: the caulis Sargentodoxae is used in the same way as caulis Sargentodoxae, has stronger fragrance and better effect, but grows less, and is replaced by caulis Sargentodoxae when the caulis Sargentodoxae does not exist.
5. The traditional Chinese medicine composition for treating cervical and lumbar vertebra diseases according to claim 1, which is characterized in that: the sanguis Draxonis contains dracorhodin, demethyl dracorhodin, flavanol, chalcone, and resin acid.
6. The traditional Chinese medicine composition for treating cervical and lumbar vertebra diseases according to claim 1, which is characterized in that: the spina Gleditsiae contains flavonoid glycoside, phenols, amino acids, quercetin, fisetin, fustin, leucocyanidin, and palmitic acid.
7. The traditional Chinese medicine composition for treating cervical and lumbar vertebra diseases according to claim 1, which is characterized in that: 50-200 parts of spina gleditsiae, 400-1500 parts of caulis spatholobi, 7-30 parts of rhizoma drynariae, 6-25 parts of eucommia ulmoides, 2-4 parts of lycopodium clavatum, 1-3 parts of cucumber seeds, 3-5 parts of ground beeltle, 3-5 parts of salvia miltiorrhiza, 3-6 parts of rhizoma gastrodiae, 2-6 parts of oldenlandia diffusa, 3-7 parts of dragon's blood, 1-2 parts of dalbergia wood and 1-3 parts of parasitic loranthus, and then soaking the cleaned and dried materials in 3000 parts of wine containing 1500-part of astaxanthin extract, 0.6-0.8 part of astaxanthin extract and 2-3 parts of abelmoschus manihot extract, wherein the medicinal liquor is taken twice a day, and the.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010384711.9A CN111529629A (en) | 2020-05-09 | 2020-05-09 | Traditional Chinese medicine composition for treating cervical vertebra and lumbar vertebra bone diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010384711.9A CN111529629A (en) | 2020-05-09 | 2020-05-09 | Traditional Chinese medicine composition for treating cervical vertebra and lumbar vertebra bone diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111529629A true CN111529629A (en) | 2020-08-14 |
Family
ID=71970617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010384711.9A Pending CN111529629A (en) | 2020-05-09 | 2020-05-09 | Traditional Chinese medicine composition for treating cervical vertebra and lumbar vertebra bone diseases |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111529629A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103721080A (en) * | 2013-12-31 | 2014-04-16 | 吴宝海 | Traditional Chinese medicine composition for treating cervical spondylosis, lumbar spondylosis and sciatica |
CN106880701A (en) * | 2017-03-30 | 2017-06-23 | 贵阳中医学院 | A kind of compound osteitis bar cloth pastes the preparation method of Chinese medical concrete |
CN110934902A (en) * | 2019-12-06 | 2020-03-31 | 赵国义 | Traditional Chinese medicine composition for treating lumbar disc herniation |
-
2020
- 2020-05-09 CN CN202010384711.9A patent/CN111529629A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103721080A (en) * | 2013-12-31 | 2014-04-16 | 吴宝海 | Traditional Chinese medicine composition for treating cervical spondylosis, lumbar spondylosis and sciatica |
CN106880701A (en) * | 2017-03-30 | 2017-06-23 | 贵阳中医学院 | A kind of compound osteitis bar cloth pastes the preparation method of Chinese medical concrete |
CN110934902A (en) * | 2019-12-06 | 2020-03-31 | 赵国义 | Traditional Chinese medicine composition for treating lumbar disc herniation |
Non-Patent Citations (4)
Title |
---|
崔同寅: "《全国重名易混中药鉴别手册》", 31 October 1992, 中国医药科技出版社 * |
朱兆云: "《云南天然药物图鉴 第9卷》", 31 December 2015, 云南科技出版社 * |
朱克俭: "《实用临床中药手册》", 31 December 2008, 湖南科学技术出版社 * |
罗国海: "《天然药物学》", 31 July 2007, 河南科学技术出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108403911A (en) | A kind of medicinal liquor for treating traumatic injury | |
CN1895600A (en) | Chinese-medicinal suppository for treating lumbar vertebrae disease | |
CN111529629A (en) | Traditional Chinese medicine composition for treating cervical vertebra and lumbar vertebra bone diseases | |
CN104587226A (en) | Traditional Chinese medicine for treating ankylosing myelitis and lumbar disc herniation and use method thereof | |
CN110227117A (en) | It is a kind of to treat osteoproliferation, pharmaceutical composition of lumbocrural pain and preparation method thereof | |
CN115227678A (en) | A Chinese medicinal patch for treating hyperosteogeny and bony spur | |
CN102670904A (en) | Internal medicament for treating prolapse of lumbar intervertebral disc | |
CN101249187B (en) | Chinese medicine for curing neck protrusion of lumbar vertebral disc | |
CN111358915A (en) | Traditional Chinese medicine for treating congenital muscular torticollis and preparation method thereof | |
CN1231253C (en) | Chinese medicine compositior for treating intervertebral disc osteoproliferation | |
CN109908246A (en) | The external application Chinese medicine formula for treating lumbar pain orthopaedic disease | |
CN111557973A (en) | Medicine for treating cervical vertebra and lumbar vertebra bone diseases | |
CN112755134B (en) | Plaster for treating hyperosteogeny and preparation method thereof | |
CN102614350A (en) | Chinese medicine for treating cervical spondylosis | |
CN101744901B (en) | Medicinal pillow for treating cervical spondylosis | |
CN105213815A (en) | Chinese medicine composition being used for the treatment of cervical spondylosis and preparation method thereof | |
CN101850011A (en) | External medicament for treating cervical spondylosis and preparation method thereof | |
CN105434818A (en) | Traditional Chinese medicine preparation for treating cervical spondylosis | |
CN1320900C (en) | Bone erosion renewel pill | |
CN111956714A (en) | Medicine for treating hyperosteogeny of cervical vertebra, lumbar vertebra and knee joint and protrusion of lumbar vertebral disc | |
CN103977101A (en) | Traditional Chinese medicine composition for treating spur | |
CN110638942A (en) | Yao medicine capsule for treating cervical vertebra pain and preparation method thereof | |
CN117064204A (en) | Traditional Chinese medicine pillow | |
CN100345576C (en) | Medicine composition for treating cervical vertebra, lumbar vertebrae diseases and preparation method thereof | |
CN114146123A (en) | Capsule for treating traumatic injury |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200814 |
|
RJ01 | Rejection of invention patent application after publication |